Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Chemical Communications (Cambridge, England)
|
June 16, 2026
Defect-state-controlled carrier recombination dynamics in nonmetal-doped brookite TiO<sub>2</sub>
Yucui Xiang, Ke Long, Dazhong Sun, et al.
The Plant Cell
|
October 18, 2023
The NLR immune receptor ADR1 and lipase-like proteins EDS1 and PAD4 mediate stomatal immunity in Nicotiana benthamiana and Arabidopsis
Hanling Wang, Susheng Song, Shang Gao, et al.
Nature Cancer
|
October 1, 2024
Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Nature Cancer
|
September 6, 2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Cancer Cell
|
July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Huairui Yuan, Ying Han, Xuege Wang, et al.
Molecular Cell
|
May 1, 2021
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
Qiang Pan, Shanshan Zhong, Hanling Wang, et al.
Cell Stem Cell
|
March 22, 2025
Vagal pathway activation links chronic stress to decline in intestinal stem cell function
Guoying Zhang, Yannan Lian, Qingguo Li, et al.
The Journal of Clinical Investigation
|
March 1, 2022
Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity
Jiale Ren, Ni Li, Siyu Pei, et al.
Nature Communications
|
November 26, 2022
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Ni Li, Qiuli Liu, Ying Han, et al.
Cancer Cell
|
April 25, 2025
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
Jiacheng Guo, Ni Li, Qiuli Liu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Chemical Communications (Cambridge, England)
|
June 16, 2026
Defect-state-controlled carrier recombination dynamics in nonmetal-doped brookite TiO<sub>2</sub>
Yucui Xiang, Ke Long, Dazhong Sun, et al.
The Plant Cell
|
October 18, 2023
The NLR immune receptor ADR1 and lipase-like proteins EDS1 and PAD4 mediate stomatal immunity in Nicotiana benthamiana and Arabidopsis
Hanling Wang, Susheng Song, Shang Gao, et al.
Nature Cancer
|
October 1, 2024
Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Nature Cancer
|
September 6, 2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Cancer Cell
|
July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Huairui Yuan, Ying Han, Xuege Wang, et al.
Molecular Cell
|
May 1, 2021
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
Qiang Pan, Shanshan Zhong, Hanling Wang, et al.
Cell Stem Cell
|
March 22, 2025
Vagal pathway activation links chronic stress to decline in intestinal stem cell function
Guoying Zhang, Yannan Lian, Qingguo Li, et al.
The Journal of Clinical Investigation
|
March 1, 2022
Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity
Jiale Ren, Ni Li, Siyu Pei, et al.
Nature Communications
|
November 26, 2022
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Ni Li, Qiuli Liu, Ying Han, et al.
Cancer Cell
|
April 25, 2025
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
Jiacheng Guo, Ni Li, Qiuli Liu, et al.
Page
of 3